Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors

Clinical trial NCT02835833 · COMPLETED

Trial details

NCT number: NCT02835833
Sponsor: University of Alabama at Birmingham
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Cell Carcinoma Colorectal Adenocarcinoma Non-squamous Non-small Cell Lung Cancer Platinum-refractory Ovarian Carcinoma Cervical Carcinoma

Start date: 2016-06-09
Primary completion: 2018-04-14
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.